Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing the previous v3.6.3, signaling a minor metadata update to the page rather than substantive content changes.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3 on the page's document section, indicating an updated version of the study materials.SummaryDifference0.0%

- Check49 days agoChange DetectedRecruitment status on the study page now indicates enrollment is closed, signaling that new participants cannot join. Additional changes include the addition of help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and an updated revision note (Revision: v3.6.0), while the old 'Intervention / Treatment' label and the prior revision text were removed.SummaryDifference0.4%

- Check56 days agoChange DetectedThe page's revision tag has been updated from v3.5.4 to v3.5.5, representing a small system version update for the page and suggesting no change to the study information.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4. This indicates a newer page version and potential updates to the documentation or content.SummaryDifference0.0%

- Check99 days agoChange DetectedThis updates the website’s displayed revision/version number from v3.5.0 to v3.5.3, reflecting a documentation or platform release rather than any change to the clinical trial content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.